Skip to content
Screener

Prestige Consumer Healthcare PBH North American OTC Healthcare — Total revenues

Other segment segments

International OTC Healthcare
$39.5M+6.9%

Similar metrics at other companies

Bausch + Lomb logo
BLCOOTC — Total revenues
$497M+3.1%
Artivion logo
AORTNorth America — Total revenues
$62.33M+8.3%
QuidelOrtho Corporation logo
QDELNorth America — Total revenues
$327.4M+5.4%
Veeva Systems logo
VEEVNorth America — Total revenues
$526.17M+14.5%
LanzaTech Global, Inc. logo
LNZANorth America — Total revenues
$2.59M-12.8%
PowerFleet, Inc. logo
AIOTNorth America — Total revenues
$39.34M+4.1%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)Three Months Ended June 30, 2026 / North American OTCHealthcareThree Months Ended June 30, 2026 / International OTCHealthcareConsolidated
Total segment revenues*$226,206$39,504$265,710
Cost of sales110,26519,257129,522
Gross profit115,94120,247136,188
Advertising and marketing28,9305,73834,668
Contribution margin$87,011$14,509$101,520
Other operating expenses49,000
Operating income$52,520
* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's north american OTC healthcare — total revenues?
Prestige Consumer Healthcare (PBH) reported north american OTC healthcare — total revenues of $226.21M in Q2 2026.
How has Prestige Consumer Healthcare's north american OTC healthcare — total revenues changed year-over-year?
Prestige Consumer Healthcare's north american OTC healthcare — total revenues increased by 6.4% year-over-year, from $212.58M to $226.21M.
What is the long-term trend for Prestige Consumer Healthcare's north american OTC healthcare — total revenues?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's north american OTC healthcare — total revenues has grown at a -1.4% compound annual growth rate (CAGR), from $967.88M to $913.58M.
What does north american OTC healthcare — total revenues mean?
The total gross income generated by the North American OTC healthcare segment from the sale of over-the-counter products to customers. This is a primary indicator of the segment's market demand, pricing power, and overall scale within the consumer healthcare industry.

Ask your AI about Prestige Consumer Healthcare's north american otc healthcare — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude